Viral Hepatitis Overview (A-E)

Viral hepatitis is one of the highest-yield topics on USMLE Step 1, and it gets tested from multiple angles simultaneously. You need to know each virus's genome type, transmission route, and chronicity risk — but the exam rarely asks these in isolation. More commonly, you'll get a clinical vignette where the transmission history, serologic pattern, or complication narrows you to a specific virus. The tricky part is that hepatitis A through E have enough overlap (all cause elevated AST/ALT, jaundice, RUQ pain) that you can't rely on symptoms alone — you have to work from epidemiologic clues and serology.

Where students consistently lose points: confusing the chronicity rates of HBV vs. HCV in adults, missing the HBV window period on serology, and forgetting that hepatitis E is largely benign unless the patient is pregnant. USMLE Step 1 loves the HBV window period because it looks like 'no infection' on a surface antigen test — students who don't know to check anti-HBc IgM get it wrong every time. Similarly, HCV chronicity (~75-85% of adult infections) is routinely underestimated because students anchor on HBV being 'the chronic one.'

Extrahepatic manifestations are another favorite angle — especially for HCV, which connects to cryoglobulinemia, MPGN, and porphyria cutanea tarda. These are testable because they look like unrelated organ pathology until you recognize the HCV link. The exam will give you a patient with purpura, renal disease, or skin blistering and expect you to trace it back to a hepatitis virus.

From real student decks

92%have cards covering this topic

73%have mature cards

1.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake

Gap: Misses that hepatitis E carries uniquely high mortality in pregnancy compared to other hepatitis viruses

Hepatitis E has a dramatically increased mortality in pregnant women (up to 20-25%), making pregnancy the key high-risk scenario to recognize for HEV.

Most students learn that hepatitis E is a self-limited, fecal-oral illness similar to hepatitis A and then mentally file it as 'benign.' That's true in most populations — but in pregnant women, HEV carries a mortality rate of 20-25%, dramatically higher than any other hepatitis virus in pregnancy. The mechanism isn't fully established but involves immune dysregulation in pregnancy. Whenever a Step 1 question puts HEV in a pregnant patient, that's your cue: this is a high-risk scenario, not a routine 'will resolve on its own' case.

Common mistake

Wrong: Hepatitis B is more likely to become chronic than hepatitis C in adults.

Right: Hepatitis C becomes chronic in approximately 75-85% of adult infections, compared to only 5-10% for hepatitis B acquired in adulthood.

The 'HBV is the chronic one' mental model is the most common error here. HBV does chronify, but the rate in adults who acquire it is only 5-10% — most adults clear it. The flip side is that HCV becomes chronic in roughly 75-85% of adults who are infected, making it far more likely to persist. The confusion often stems from mixing up neonatal HBV (where chronicity is ~90%) with adult HBV. When the exam asks about chronicity in an adult who was exposed parenterally, HCV wins by a wide margin.

Common mistake

Wrong: A patient with no detectable HBsAg and no anti-HBs antibody has never been infected with hepatitis B.

Right: The absence of both HBsAg and anti-HBs with positive anti-HBc IgM indicates the window period of acute HBV infection, where HBsAg has cleared but anti-HBs has not yet appeared.

Students assume that negative HBsAg means no active infection and negative anti-HBs means no immunity — so 'both negative' gets interpreted as never infected. That's wrong in one specific scenario: the window period of acute HBV. After HBsAg clears but before anti-HBs appears, the only detectable marker is anti-HBc IgM. If you don't check for anti-HBc IgM, you'll miss acute HBV entirely. Any Step 1 serology question with HBsAg negative, anti-HBs negative, and a compatible clinical picture needs you to think window period first.

Common mistake

Gap: Misses the classic extrahepatic manifestations of HCV, particularly cryoglobulinemia and MPGN

HCV is associated with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda as key extrahepatic manifestations.

HCV is uniquely associated with extrahepatic immune-complex and metabolic diseases that the exam tests as separate organ pathology. Essential mixed cryoglobulinemia (type II) presents with purpura, arthralgias, and weakness — the immune complexes deposit in small vessels. Those same complexes can cause MPGN, presenting with hematuria and proteinuria. Porphyria cutanea tarda manifests as blistering photosensitive skin lesions on sun-exposed areas. The exam will describe these findings without mentioning hepatitis — your job is to recognize the HCV connection and ask about risk factors for HCV in that patient.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

For each hepatitis virus (A through E), know the genome type (RNA vs. DNA), primary transmission route (fecal-oral vs. parenteral vs. sexual), and whether the virus can establish chronic infection — this is the foundational mapping the exam builds clinical questions on.
Know the relative chronicity rates across all five hepatitis viruses — especially that HCV becomes chronic in approximately 75-85% of adult infections, making it more likely to chronify than HBV acquired in adulthood (~5-10% chronic in adults).
Recognize the extrahepatic manifestations of hepatitis viruses, particularly HCV's association with essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis (MPGN), and porphyria cutanea tarda — the exam will present these as separate organ findings and expect you to identify the viral cause.

Can you avoid these mistakes?

A 32-year-old woman in her third trimester presents with acute jaundice, elevated transaminases, and recent travel to South Asia. She reports drinking well water during the trip. Which hepatitis virus is most likely responsible, and what makes this clinical scenario particularly dangerous compared to the typical course of this infection?

A 28-year-old man who uses IV drugs has HBsAg negative, anti-HBs negative, and anti-HBc IgM positive. His ALT is 15x the upper limit of normal. What is the most likely diagnosis, and what is the significance of the anti-HBc IgM result?

A 45-year-old woman is found to have HCV infection. She reports no symptoms referrable to the liver. Her physician notes palpable purpura on both lower extremities and urinalysis shows 2+ protein and red cell casts. What extrahepatic manifestations of HCV explain this presentation, and what is the underlying immune mechanism?

A patient asks about their risk of chronic infection after two separate needle-stick exposures — one with HBV-positive blood and one with HCV-positive blood. Assuming no prior vaccination or immunity, which exposure carries higher risk of leading to chronic hepatitis, and approximately what is that chronicity rate?

Viral Hepatitis Overview (A-E)

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics